PLN and stroke disorder: To determine whether perlecan is required for the acute neuroprotective effects of IL-1α after stroke, we used a perlecan hypomorph (pln KO) mouse that expresses 10% of normal total perlecan levels (and hence 10% of normal total perlecan LG3; complete perlecan knockout mice are embryonic lethal).